SJS eye injuries can continue long after the acute hospitalization
Stevens-Johnson syndrome and toxic epidermal necrolysis are often evaluated through the dramatic acute phase - blistering, skin detachment, mucosal injury, ICU or burn-center treatment, and the risk of death. For many survivors, however, the most disabling injuries emerge or persist after the acute reaction has ended. The eyes are among the organs most vulnerable to long-term damage.
A multicenter cohort study published online September 18, 2026 in the American Journal of Ophthalmology provides new data about chronic ocular SJS, including which findings predict later surgery and vision loss. The study reinforces why long-term ophthalmology and cornea records can be essential when evaluating the full severity and value of an SJS/TEN case.
What the 2026 study found
Researchers analyzed 228 eyes from 115 patients with chronic ocular Stevens-Johnson syndrome. The median delay before presentation to a specialized center was one year. At presentation, 83.3% of eyes had superficial punctate keratitis, 71.9% conjunctival hyperemia, 59.2% limbal stem-cell deficiency, 54.3% symblepharon, 48.2% corneal neovascularization, 47.3% trichiasis, and 42.5% lid-margin keratinization.
More than half of the eyes - 53.5% - underwent surgery during follow-up. Mucous-membrane grafting was the most common procedure. Lid-margin keratinization was a particularly strong predictor of needing surgery, with an adjusted odds ratio of 11.5. Conjunctivalization was also associated with surgical intervention.
Why lid-margin keratinization matters
Lid-margin keratinization can cause the normally non-keratinized inner eyelid surface to become rough and damaging to the ocular surface. With every blink, that altered surface can produce chronic mechanical trauma to the cornea. Over time, patients may develop persistent inflammation, epithelial breakdown, scarring, neovascularization, limbal stem-cell failure, and severe visual impairment.
For legal case development, a notation such as lid-margin keratinization should not be treated as a minor ophthalmology detail. The new study supports its role as an important marker of serious chronic ocular disease and future surgical burden.
The study also highlights the importance of long-term records
The median one-year delay before specialized presentation is important. A patient may leave the hospital alive and appear to have survived the principal crisis while ocular disease continues to evolve. Damages analysis limited to the initial admission can therefore materially understate the injury.
Relevant records may include inpatient ophthalmology consultations, outpatient cornea and ocular-surface visits, visual-acuity measurements, slit-lamp examinations, photographs, amniotic-membrane treatment records, scleral or PROSE lens care, mucous-membrane grafting, limbal stem-cell procedures, corneal transplantation, medication history, and documentation of dry eye, photophobia, pain, trichiasis, symblepharon, neovascularization, and functional vision loss.
A causation caution in interpreting the medication findings
The study reported associations between later vision loss and certain categories of suspected causative agents, including antibiotics and NSAIDs. Those associations should be interpreted cautiously. This was an observational cohort of patients who already had chronic ocular SJS; it was not designed to prove that antibiotics or NSAIDs cause worse eye outcomes than other culprit medications.
Medication causation in an individual case remains a separate inquiry requiring exposure timing, alternative causes, competing medications, clinical adjudication, and other case-specific evidence. The ocular study is strongest as evidence about severity, prognosis, and the need for long-term follow-up rather than as a drug-specific liability study.
Legal and case-evaluation implications
For a serious SJS/TEN claim, permanent or progressive eye injury can substantially affect damages. Vision loss, chronic pain, photophobia, repeated surgeries, inability to tolerate ordinary lighting, loss of driving ability, work limitations, dependency on specialty lenses, and future surgical care may continue for years.
Intake and litigation teams should therefore ask more than whether the patient had eye involvement during hospitalization. They should determine whether the patient has ongoing cornea or ocular-surface treatment, whether lid-margin keratinization or limbal stem-cell deficiency has been diagnosed, whether surgeries have been performed or recommended, and whether vision has deteriorated over time.
In appropriate cases, delayed recognition or inadequate acute ocular management may also require separate medical-negligence analysis. The 2026 cohort does not establish a malpractice standard, but it reinforces that specialized ocular follow-up is clinically consequential.
What patients and families should preserve
Patients and families evaluating a potential SJS/TEN claim should preserve records from every eye-care provider, not merely the hospital where the acute reaction occurred. Useful material includes operative reports, specialist notes, visual-acuity histories, photographs, lens prescriptions, bills for specialty devices, records of missed work or inability to drive, and documentation of future recommended care.
Because SJS/TEN can produce progressive ocular damage, a case should not be valued solely from the first few weeks of medical records. Long-term prognosis may change the legal and economic significance of the injury.
Sources
Predictors of Vision Loss and Surgical Intervention in Stevens-Johnson Syndrome: A Multicenter Nationwide Cohort Study, American Journal of Ophthalmology DOI: 10.1016/j.ajo.2026.09.020. Direct source